<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The biological and clinical <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> features renders its classification difficult </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, because of the limited knowledge of the mechanisms involved in malignant evolution, <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> remains a diagnostic and therapeutic challenge and a poor prognosis disease </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to verify the biological and clinical significance of the discrimination, based on the leukocyte count, between myelodysplastic <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (MD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) and myeloproliferative <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (MP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>EXPERIMENTAL DESIGN: Peripheral blood samples from 22 patients classified as MD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> and 18 as MP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> were collected at different time points during disease course, and patients' clinical characteristics were examined </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0011356'>RAS</z:mp> mutational screening was done by sequencing and, for each substitution identified, a highly selective allele-specific PCR was set up to screen <z:hpo ids='HP_0000001'>all</z:hpo> specimens </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: MP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> patients showed a significantly poorer survival (P = 0.003) and a higher frequency of <z:mp ids='MP_0011356'>RAS</z:mp> mutations (P = 0.033) by sequencing compared with MD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Overall, five MD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> patients progressed to <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath>: in two, allele-specific PCR unveiled low levels of the <z:mp ids='MP_0011356'>RAS</z:mp> mutations predominating in the myeloproliferative phase at the time of myelodysplastic disease, documenting for the first time the expansion of a <z:mp ids='MP_0011356'>RAS</z:mp> mutated clone in concomitance with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> evolution </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, one of the progressed patients harbored the FLT3-ITD and two MP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> patients presented with the JAK2 V617F substitution </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these lesions were mutually exclusive </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Our results strongly suggest <z:mp ids='MP_0011356'>RAS</z:mp> mutations to function as a secondary event that contributes to development of the <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> variant with the poorer prognosis (MP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) and therefore advise their detection to be implemented in <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> diagnostics and monitoring </plain></SENT>
</text></document>